Safety and Tolerability of Weekly Genexol-PM, a Cremophor-Free Polymeric Micelle Formulation of Paclitaxel, with Carboplatin in Gynecologic Cancer: A Phase I Study

PURPOSE: This phase I study was conducted to determine the maximum tolerated dose and the recommended phase II dose of weekly administered Genexol-PM combined with carboplatin in patients with gynecologic cancer. MATERIALS AND METHODS: This open-label, phase I, dose-escalation study of weekly Genexo...

Descripción completa

Detalles Bibliográficos
Autores principales: Nam, So Hyun, Lee, Shin-Wha, Lee, Young-Jae, Kim, Yong Man
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582543/
https://www.ncbi.nlm.nih.gov/pubmed/37189263
http://dx.doi.org/10.4143/crt.2022.1436

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582543/
https://www.ncbi.nlm.nih.gov/pubmed/37189263
http://dx.doi.org/10.4143/crt.2022.1436

Ejemplares similares